All Articles

Kids In Need Foundation's massive 2026 effort reveals a masterclass in logistics and a stark look at how basic school supplies build confidence and equity.

The strategic acquisition combines engineered probiotics with CRISPR-based technology, creating a powerful new toolkit to revolutionize livestock health.

New data shows 84% of Americans needing substance use treatment don't get it. A new approach combines neuroscience and faith to rewire the brain for recovery.

Mitsubishi unveils its most ambitious US plan in decades, promising new EVs, a Nissan-built pickup, and rugged SUVs. But can it overcome a skeptical dealer network?

A Charlotte dog care brand's first franchise is more than a local story. It's a look at how tech, human capital, and smart incentives are transforming the $150B pet industry.

Allegheny Health Network and START's new partnership isn't just a local win; it's a blueprint for a more accessible, patient-centric future in oncology.

A small biophysics firm unveils promising data for its at-home headset using magnetic fields to treat Long COVID, heralding a potential shift from pharma to biophysics.

A routine tender offer extension for a small healthcare operator reveals a larger story of a struggling company, a persistent buyer, and a new regulatory era.

A new partnership aims to bring AI and cloud tech to the Farm Credit System. What does this mean for farmers, rural economies, and the future of food?

Festool's integration of Shaper's handheld CNC tech is more than a merger; it's a blueprint for the future of woodworking. What does this mean for artisans?

As Lumexa Imaging execs hit the road for a four-conference tour, is it a victory lap for recent profits or a strategic play to manage debt and woo investors?

Quest Diagnostics is bringing longevity science to the masses with a new biological age test. Sandra Patterson explores the investment and ethical calculus.

Halcones Precious Metals pays for another delay at its Polaris project, battles for land access in a Chilean court, and abruptly replaces its CEO.

A new blood test can predict preterm birth risk months in advance, shifting prenatal care from reactive crisis to proactive strategy and saving billions.

With a stunning 26.1% return on equity and a 36% surge in asset management, Phoenix Financial isn't just growing; it's rewriting its playbook.

The 2026 CSHF ceremony honors legends like The Tragically Hip and Feist while passing the torch to new voices, amplified by a global digital strategy.

As connected devices multiply, Finite State’s AI-native platform, a TechForward finalist, offers a new paradigm for managing risk and ensuring compliance.

CLO Virtual Fashion's patent win against Style3D is more than a legal victory; it's a landmark moment for IP rights in the digital age. What does this mean for innovation?

New studies show AI can quantify subtle lung damage, offering hope for earlier, more personalized treatment of Interstitial Lung Disease. What does this mean?

A landmark patent settlement in 3D fashion is more than a legal victory; it's a strategic warning that will redefine competition and the high cost of innovation.